[go: up one dir, main page]

MX2010005112A - Procesos e intermediarios para producir aminobencimidazol ureas. - Google Patents

Procesos e intermediarios para producir aminobencimidazol ureas.

Info

Publication number
MX2010005112A
MX2010005112A MX2010005112A MX2010005112A MX2010005112A MX 2010005112 A MX2010005112 A MX 2010005112A MX 2010005112 A MX2010005112 A MX 2010005112A MX 2010005112 A MX2010005112 A MX 2010005112A MX 2010005112 A MX2010005112 A MX 2010005112A
Authority
MX
Mexico
Prior art keywords
intermediates
processes
aminobenzimidazole
ureas
producing
Prior art date
Application number
MX2010005112A
Other languages
English (en)
Inventor
Raymond Forslund
Derek Magdziak
Yong Dong
Gerald Tanoury
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40626429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010005112(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX2010005112A publication Critical patent/MX2010005112A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención se refiere a procesos e intermediarios para la preparación de compuestos útiles como inhibidores de girasa bacteriana y Topoisomerasa IV (Topo IV).
MX2010005112A 2007-11-07 2008-11-06 Procesos e intermediarios para producir aminobencimidazol ureas. MX2010005112A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98614107P 2007-11-07 2007-11-07
PCT/US2008/082565 WO2009061875A2 (en) 2007-11-07 2008-11-06 Processes and intermediates for producing aminobenzimidazole ureas

Publications (1)

Publication Number Publication Date
MX2010005112A true MX2010005112A (es) 2010-07-28

Family

ID=40626429

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005112A MX2010005112A (es) 2007-11-07 2008-11-06 Procesos e intermediarios para producir aminobencimidazol ureas.

Country Status (14)

Country Link
US (1) US20090149651A1 (es)
EP (1) EP2215081A2 (es)
JP (1) JP2011503091A (es)
KR (1) KR20100095559A (es)
CN (1) CN101903376A (es)
AR (1) AR069245A1 (es)
AU (1) AU2008323994A1 (es)
CA (1) CA2704990A1 (es)
CL (1) CL2008003314A1 (es)
IL (1) IL205575A0 (es)
MX (1) MX2010005112A (es)
RU (1) RU2010123003A (es)
TW (1) TW200927743A (es)
WO (1) WO2009061875A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5222632B2 (ja) * 2008-06-13 2013-06-26 白鳥製薬株式会社 ビアリール化合物の製造方法
EP2593447B1 (de) 2010-07-15 2016-08-17 Bayer Intellectual Property GmbH 3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel
KR101209736B1 (ko) 2010-09-30 2012-12-07 기아자동차주식회사 가변 밸브 리프트 장치
WO2015114452A2 (en) 2014-02-03 2015-08-06 Biota Europe Ltd Antibacterial compounds
WO2018174288A1 (ja) 2017-03-24 2018-09-27 大正製薬株式会社 ２（１ｈ）－キノリノン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618974B2 (en) * 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof

Also Published As

Publication number Publication date
RU2010123003A (ru) 2011-12-20
CL2008003314A1 (es) 2010-01-04
CA2704990A1 (en) 2009-05-14
TW200927743A (en) 2009-07-01
US20090149651A1 (en) 2009-06-11
IL205575A0 (en) 2010-11-30
WO2009061875A2 (en) 2009-05-14
JP2011503091A (ja) 2011-01-27
WO2009061875A3 (en) 2009-07-23
KR20100095559A (ko) 2010-08-31
CN101903376A (zh) 2010-12-01
AU2008323994A1 (en) 2009-05-14
EP2215081A2 (en) 2010-08-11
AR069245A1 (es) 2010-01-06

Similar Documents

Publication Publication Date Title
MY150542A (en) Cmet inhibitors
TN2011000673A1 (en) Bace inhibitors
MX2011005934A (es) Compuestos organicos.
MY153915A (en) Organic compounds
PT2470546E (pt) Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor
MX2010012298A (es) Activadores de glucocinasa.
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
MX2009011255A (es) Proceso para preparar capecitabina.
MX2010002783A (es) Proceso e intermediarios para la preparacion de inhibidores de integrasa.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
GEP201706745B (en) Forms of rifaximin and usage thereof
MX2012004780A (es) Inhibidores de akt.
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
UA97806C2 (ru) Бензиламины, способ их получения и их применения в качестве противовоспалительных средств
PL2099769T3 (pl) Związki 6-okso-1,6-dihydropirymidyn-2-ylowe do leczenia chorób proliferacyjnych
MX2010005112A (es) Procesos e intermediarios para producir aminobencimidazol ureas.
PH12012501153A1 (en) Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
TWI374886B (en) Processes for preparing intermediates of pemetrexed
MX2010006636A (es) Uso de derivados de acido tetramico para controlar nematodos.
GB201107985D0 (en) Process
MX2011008126A (es) Compuestos de indol sustituidos como moduladores del receptor 1 de bradiquinina.
JO2812B1 (en) A method of obtaining the aggregate V crystal form of agomelatine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal